• Corcept Therapeutics average return on tangible equity for 2023 was 19.87, a 19.98% increase from 2022.
• Corcept Therapeutics average return on tangible equity for 2022 was 24.83, a 20.59% decline from 2021.
• Corcept Therapeutics average return on tangible equity for 2021 was 20.59, a 22.65% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.